Kelyniam Global, Inc. (KLYG)
Kelyniam Global, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Canton, CT, US. The stock last traded at $0.14, up 7.41% on the session, giving a market capitalisation of $1.8M. On trailing twelve-month figures it carries a trailing P/E of -33.72, a net margin of -6.0%. Its beta of -0.10 implies it has historically moved less than the broad market.
Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced medical-grade polymers. Additionally, Kelyniam develops, produces, and supplies specific cranial and craniofacial fixation screws, crucial for the reconstruction of skull and facial structures. Its clientele encompasses health systems, hospitals, sales representatives, surgeons, insurance providers (payors), and individual patients. Established in 2005, the company was originally named Ketner Global Investments, Inc., rebranding to Kelyniam Global, Inc. in December 2007. Kelyniam Global is based in Collinsville, Connecticut.
Kelyniam Global, Inc. is most often compared with the following Healthcare names: